Cybersecurity in Artificial Pancreas Experiments

Derek T. O'Keeffe, Spyridoula Maraka, Ananda Basu, Patrick Keith-Hynes, Yogish C Kudva

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.

Original languageEnglish (US)
Pages (from-to)664-666
Number of pages3
JournalDiabetes Technology and Therapeutics
Volume17
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Artificial Pancreas
Computer Security
Equipment and Supplies
Diabetes Mellitus
Technology
Delivery of Health Care

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Cybersecurity in Artificial Pancreas Experiments. / O'Keeffe, Derek T.; Maraka, Spyridoula; Basu, Ananda; Keith-Hynes, Patrick; Kudva, Yogish C.

In: Diabetes Technology and Therapeutics, Vol. 17, No. 9, 01.09.2015, p. 664-666.

Research output: Contribution to journalArticle

O'Keeffe, DT, Maraka, S, Basu, A, Keith-Hynes, P & Kudva, YC 2015, 'Cybersecurity in Artificial Pancreas Experiments', Diabetes Technology and Therapeutics, vol. 17, no. 9, pp. 664-666. https://doi.org/10.1089/dia.2014.0328
O'Keeffe, Derek T. ; Maraka, Spyridoula ; Basu, Ananda ; Keith-Hynes, Patrick ; Kudva, Yogish C. / Cybersecurity in Artificial Pancreas Experiments. In: Diabetes Technology and Therapeutics. 2015 ; Vol. 17, No. 9. pp. 664-666.
@article{2eaffe59fc0648e3845a68e2ad3aeb5b,
title = "Cybersecurity in Artificial Pancreas Experiments",
abstract = "Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.",
author = "O'Keeffe, {Derek T.} and Spyridoula Maraka and Ananda Basu and Patrick Keith-Hynes and Kudva, {Yogish C}",
year = "2015",
month = "9",
day = "1",
doi = "10.1089/dia.2014.0328",
language = "English (US)",
volume = "17",
pages = "664--666",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Cybersecurity in Artificial Pancreas Experiments

AU - O'Keeffe, Derek T.

AU - Maraka, Spyridoula

AU - Basu, Ananda

AU - Keith-Hynes, Patrick

AU - Kudva, Yogish C

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.

AB - Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.

UR - http://www.scopus.com/inward/record.url?scp=84940655565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940655565&partnerID=8YFLogxK

U2 - 10.1089/dia.2014.0328

DO - 10.1089/dia.2014.0328

M3 - Article

C2 - 25923544

AN - SCOPUS:84940655565

VL - 17

SP - 664

EP - 666

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 9

ER -